Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FDM33
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,190
Award facts
- Contract value 100% obligated
- $6,189.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,189.60 by the Defense Logistics Agency (DLA) on September 26, 2025. The delivery order, issued under the DLA's larger SPE2DB Indefinite Delivery Contract (valued at $499,999,999 through November 2026), calls for the supply of Xolair 150 mg/ml syringes. This award utilizes a firm fixed-price contract type with no set-aside designation, leveraging DMS Pharmaceutical Group's established position as a woman-owned small business within the federal procurement system. The contract is scheduled for ultimate completion by October 20, 2025, with the place of performance in Park Ridge, Illinois.
This delivery order represents a continuation of DMS Pharmaceutical Group's significant role as a critical supplier within the federal pharmaceutical supply chain, particularly for military healthcare facilities. The company's extensive portfolio through the SPE2DB vehicle encompasses a broad range of pharmaceutical products, including biologics, injectable medications, and specialty treatments supporting Department of Defense healthcare needs. As a registered SAM.gov vendor since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in delivering pharmaceutical products to federal agencies, making this award part of its ongoing support of military health system requirements.
Quick answers
Who was awarded contract SPE2DB25FDM33?
SPE2DB25FDM33 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FDM33 worth?
The government has obligated $6,190 on SPE2DB25FDM33.
Is contract SPE2DB25FDM33 an order under another contract?
Yes. SPE2DB25FDM33 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM33 competed?
The extent of competition for SPE2DB25FDM33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award